Selenocysteine metabolism is a targetable vulnerability in MYCN-amplified cancers
Published in 2022 by
H. Alborzinia,
U. Yildiz 
,
Freitas Fp,
J. Varga,
W. Schmitz,
B. Michalke,
J. Zheng,
S. Meierjohann,
Z. Chen,
Friedmann Angeli Jp,
Vogel Fc,
J. Batani,
C. Bartenhagen,
G. Büchel,
Andres Florez
,
Freitas Fp,
J. Varga,
W. Schmitz,
B. Michalke,
J. Zheng,
S. Meierjohann,
Z. Chen,
Friedmann Angeli Jp,
Vogel Fc,
J. Batani,
C. Bartenhagen,
G. Büchel,
Andres Florez
